Role of cytokines in the pathogenesis of thyroid-associated ophthalmopathy. 2002

Yuji Hiromatsu, and Hiroo Kaku, and Ikuyo Miyake, and Shiro Murayama, and Eri Soejima
Department of Endocrinology and Metabolism, Kurume University School of Medicine, Fukuoka, Japan. yuji@med.kurume-u.ac.jp

Thyroid-associated ophthalmopathy (TAO) is generally considered to be an autoimmune disorder associated with Graves' disease. However, the nature of autoantigen or mechanism of the development of ophthalmopathy remains unclear. In the present review we focus the accumulating evidence on roles of cytokines in the orbital tissues from patients with TAO and animal models. From the analysis of T-cell clones, T helper 1 (T(H)1)-like clones were predominant in cultures from patients with recent onset hyperthyroidism and T(H)2-like clones were predominant in culture form patients with more remote onset hyperthyroidism. T(H)1-like cytokine profiles are predominant in eye muscle tissue and related to the eye muscle enlargement, while T(H)2-like cytokine profiles are predominant in orbital fat tissue from patients with TAO and negatively related to orbital volume. Therefore, T(H)1-like cytokines, proinflammatory cytokines, may play a role on the development of eye muscle component of TAO in the acute stage. T(H)2-like cytokines, anti-inflammatory cytokines, may play protective role in the chronic stage of TAO. The studies using animal models suggest the genetic background is involved in the pathogenesis of TAO. The studies on polymorphism of the cytokine genes support the proinflammatory role of T(H)1-like cytokines and protective role of T(H)2-like cytokines.

UI MeSH Term Description Entries
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D006111 Graves Disease A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). Basedow's Disease,Exophthalmic Goiter,Goiter, Exophthalmic,Graves' Disease,Basedow Disease,Hyperthyroidism, Autoimmune,Basedows Disease,Disease, Basedow,Disease, Basedow's,Disease, Graves,Disease, Graves',Exophthalmic Goiters,Goiters, Exophthalmic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine

Related Publications

Yuji Hiromatsu, and Hiroo Kaku, and Ikuyo Miyake, and Shiro Murayama, and Eri Soejima
January 2022, Journal of immunology research,
Yuji Hiromatsu, and Hiroo Kaku, and Ikuyo Miyake, and Shiro Murayama, and Eri Soejima
January 1989, Developments in ophthalmology,
Yuji Hiromatsu, and Hiroo Kaku, and Ikuyo Miyake, and Shiro Murayama, and Eri Soejima
October 1993, Trends in endocrinology and metabolism: TEM,
Yuji Hiromatsu, and Hiroo Kaku, and Ikuyo Miyake, and Shiro Murayama, and Eri Soejima
September 1989, The Journal of endocrinology,
Yuji Hiromatsu, and Hiroo Kaku, and Ikuyo Miyake, and Shiro Murayama, and Eri Soejima
September 2008, Thyroid : official journal of the American Thyroid Association,
Yuji Hiromatsu, and Hiroo Kaku, and Ikuyo Miyake, and Shiro Murayama, and Eri Soejima
June 2017, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology,
Yuji Hiromatsu, and Hiroo Kaku, and Ikuyo Miyake, and Shiro Murayama, and Eri Soejima
January 1995, Bailliere's clinical endocrinology and metabolism,
Yuji Hiromatsu, and Hiroo Kaku, and Ikuyo Miyake, and Shiro Murayama, and Eri Soejima
January 2021, International journal of ophthalmology,
Yuji Hiromatsu, and Hiroo Kaku, and Ikuyo Miyake, and Shiro Murayama, and Eri Soejima
February 2019, Eye (London, England),
Yuji Hiromatsu, and Hiroo Kaku, and Ikuyo Miyake, and Shiro Murayama, and Eri Soejima
March 2014, Investigative ophthalmology & visual science,
Copied contents to your clipboard!